Natco Pharma share news and announcements
NSE: NATCOPHARMBSE: 524816Pharmaceuticals & BiotechnologySmall Cap
Last close ₹791.85up ₹6.70 (0.85%)BSE ₹792.20
Share price at the NSE close on 23 Oct 2026. Previous close ₹785.15.
52-week range of traded prices to 23 Oct 2026
₹773.60Low, 22 Oct 2026₹1,226.80High, 12 May 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹15,534 Cr380th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 14 Aug 2026
- 13.6
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.57%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 14 Aug 2026
- 13.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 14 Aug 2026
- 8.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 29 May 2026
- 0.08
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 5,69,53550.8% delivered
Natco Pharma record dates, bonuses and splits
46 filed, newest first.
Sep 2026
25 Sep · Corporate action
9 Sep · Corporate action
Aug 2026
14 Aug · Corporate action
Feb 2026
12 Feb · Corporate action
Nov 2025
Aug 2025
12 Aug · Corporate action
Nov 2024
12 Nov · Corporate action
Sep 2024
Aug 2024
12 Aug · Corporate action
Feb 2024
14 Feb · Corporate action
Nov 2023
14 Nov · Corporate action
Sep 2023
Aug 2023
9 Aug · Corporate action
Feb 2023
9 Feb · Corporate action
Nov 2022
10 Nov · Corporate action
Sep 2022
Aug 2022
9 Aug · Corporate action
Feb 2022
14 Feb · Corporate action
Nov 2021
11 Nov · Corporate action
Sep 2021
Aug 2021
12 Aug · Corporate action
Feb 2021
11 Feb · Corporate action
Nov 2020
Sep 2020
Aug 2020
12 Aug · Corporate action
Jun 2020
Feb 2020
Nov 2019
Aug 2019
May 2019
Feb 2019
Aug 2018
Feb 2018
Aug 2017
Feb 2017
Aug 2016
Feb 2016
Nov 2015
Feb 2015
11 Feb · Corporate action
Company has fixed Record Date as February 25, 2015 for the purpose of payment of interim dividend.
Feb 2014
13 Feb · Corporate action
Company has fixed Record Date as February 25, 2014 for the purpose of Interim dividend
Feb 2013
13 Feb · Corporate action
Company has fixed Record Date as February 25, 2013 for the purpose of payment of interim dividend.
Feb 2012
9 Feb · Corporate action
Date for taking a record of its shareholders eligible for the purpose of payment of Interim Dividend i.e. record date is fixed as February 23, 2012. The said interim dividend pay-by-date is March 01, 2012.
Feb 2011
14 Feb · Corporate action
Board of Directors of the Company at its meeting held on February 14, 2011 has fixed February 25, 2011 as the record date for the purpose of payment of interim dividend.
Jan 2010
27 Jan · Corporate action
Record date for the purpose of payment of interim dividend, declared at the board meeting held on January 27, 2010, is fixed as February 08, 2010.